Development of Trypsin-Like Serine Protease Inhibitors as Therapeutic Agents: Opportunities, Challenges, and their Unique Structure-Based Rationales

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|16|13|1506-1529

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.16, Iss.13, 2016-05, pp. : 1506-1529

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic applications of serine protease inhibitors

By Ilies Marc A   Supuran Claudiu T   Scozzafava Andrea  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 8, 2002-08 ,pp. : 1181-1214

Informa Healthcare

Access to resources Recommend Favorite

Recent Advances in Serine Protease Inhibitors as Anticoagulant Agents

By  

Current Pharmaceutical Design, Vol. 13, Iss. 3, 2007-01 ,pp. : 287-312

Bentham Science Publishers

Access to resources Recommend Favorite

New Approaches to Structure-Based Discovery of Dengue Protease Inhibitors

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 9, Iss. 3, 2009-06 ,pp. : 327-343

Bentham Science Publishers

Access to resources Recommend Favorite

New Opportunities in the Structure-based Design of Anti-Protozoan Agents

By  

Current Topics in Medicinal Chemistry, Vol. 17, Iss. 1, 2017-01 ,pp. : 79-90

Bentham Science Publishers

Access to resources Recommend Favorite

Challenges and opportunities for new protein crystallization strategies in structure-based drug design

By Grey Jessica Lynn   Thompson David H  

Expert Opinion on Drug Discovery, Vol. 5, Iss. 11, 2010-11 ,pp. : 1039-1045

Informa Healthcare

Access to resources Recommend Favorite